Location: Home
  • search
  • go
  • Relate News
  • 2/19/2024Trends in the Disease Burden of Anxiety Disorders in Middle-Aged and O...
  • 2/16/2024FDA Criticizes Chinese API Producer for Deceptive Practices and Qualit...
  • 2/16/2024Ethical Concerns Prompt Largest Mass Retraction of Chinese Genetics Pa...
  • 2/16/2024China CDC Becomes First WHO Collaboration Centre on Injury Prevention ...
  • 2/16/2024Anti-China Biotech Policy: Biosecure & Beyond (BioCentury Video)
  • 2/16/2024As U.S.-China Biotech Tensions Rise, Korea Holds Its Breath (Korean Jo...
  • 2/15/2024LianBio Completes Strategic Review for Winding Down of Its Operations
  • 2/10/2024Drug R&D and Product Registration News Digest February 2024 (1)
  • 2/10/2024Recent Executive Moves
  • 2/8/2024China Issues the Action Plan for National Emergency Clinical Trials fo...
  • 2/8/2024China Drug Sales Performance of Top Seven MNC Pharma Cos in 2023
  • 2/8/2024Fresh Formulas for Growth: Assessing Asia in the New Year (PharmExec)
  • 2/7/2024NHSA Solicits Comments for Draft Incentive Document on Initial Pricing...
  • 2/7/2024NMPA Issues the Pilot Reform Work Plan for Optimizing Drug Supplementa...
  • 2/7/2024China Proposes Accelerated Approval for Local Production of Biologics
  • 2/7/2024I-Mab to Divest China Operations and Become a US-Focused Biotech
  • 2/7/2024NHC: China Continues to Improve Access to Public Medical Services
  • 2/7/2024Boao Lecheng Pilot Zone Experiments Expedited Entry into China's Healt...
  • 2/7/2024China's Basic Medical Insurance System Reports Revenue of CNY 2.7T in ...
  • 2/7/2024Review of Chinese Anti-tumor Hospital Drug Sales in 2023: Pharnexcloud
  • 2/7/2024Review and Outlook of China's Foreign Trade of Medicines and Health Pr...
  • 2/7/2024NMPA Restores Import, Sales and Use of GSK's BPH Drug
  • 2/7/2024CDE Issues the List of Reference Formulations for GQCE Studies (77th B...
  • 2/7/2024CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
  • 2/7/2024CDE Issues the Dossier References for Drug R&D and Technical Evaluatio...
  • 2/7/2024CDE Issues the Technical Guidelines for Pharmaceutical Research on Mic...
  • 2/6/2024CDE Issues the Guidelines for Management and Review of Compliance Info...
  • 2/6/2024NMPA and Chinese Customs Announce Addition of Hefei Airport as a Drug ...
  • 2/6/2024CPC Expels Former Healthare Reform Official
  • 2/6/2024Potential Impact of the US Bill on Wuxi AppTec and Its Western Drugmak...
  • Page:17/718 Total number of articles:21530: [First][<<] [15] [16] [17] [18] [19] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group